Timuso peptidas

Thymosin Alpha-1 skaičiuoklė

Apskaičiuokite tikslius rekonstitucijos tūrius, insulino vienetus ir dozių skaičių flakone bet kuriam peptidui.

Flakonas, vanduo ir dozė žinomi

Thymosin Alpha-1Ši skaičiuoklė nustatyta peptidui Thymosin Alpha-1

Peptido kiekis (mg)

BAC vanduo (ml)

Dozė (mg)

įprastai 0.8-3.2 mg

mcgmg

Švirkšto dydis

Kalibravimas

U-100U-40

Vienetai = tūris, o ne veiklioji medžiaga

Vienetai matuoja tūrį, o ne veikliąją medžiagą. 16 IU = 0,16 ml. Kiek tame yra mg, priklauso nuo mišinio. Skaičiuoklė tai jau apskaičiavo už Jus.

Beveik visi insulino švirkštai yra U-100. Rinkitės U-40 tik tuo atveju, jei ant švirkšto pažymėta U-40.

Jūsų rezultatas · gyvai

IUmlVienetai

Įtraukite iki

16IU

16 IU / 100 IU (0.160 ml)

Koncentracija

10.00

mg/ml

Tūris vienai dozei

0.160

Dozių skaičius flakone

6.3

dozės

už dozę

—

Thymosin Alpha-1

Pagrindiniai duomenys

Dažnumas: 2–7x weekly
Įprastas diapazonas: 0,8-3,2 mg

Mokslinis profilis

Thymosin Alpha-1 peptidų leksikone: veikimo mechanizmas, įrodymai ir šaltiniai

→

What Is Thymosin Alpha-1?

Thymosin Alpha-1 (often abbreviated Tα1) is a synthetic peptide composed of 28 amino acids and carrying an acetylated N-terminus. It corresponds to a naturally occurring fragment of the precursor protein prothymosin alpha, which is produced in the thymus gland. The thymus is the central organ for the maturation of T-lymphocytes, and the thymic factors it releases govern essential steps of adaptive immunity. Thymosin Alpha-1 was first isolated in the 1970s from the thymic extract Thymosin Fraction 5 and has since become one of the most intensively studied immune-modulating peptides.

Unlike repair peptides such as BPC-157 or TB-500, whose research focus lies in tissue healing and angiogenesis, Thymosin Alpha-1 is discussed primarily in the context of immune regulation. In preclinical and clinical models it has been studied in connection with strengthening the cell-mediated immune response, normalizing immune function under conditions of immunosuppression, and moderating excessive inflammatory reactions. Approved in several countries as a pharmaceutical under the brand name Zadaxin, Thymosin Alpha-1 is used there as an adjunct in chronic hepatitis B and C and as an immune-supporting agent. In the European Union and most Western markets it holds no marketing authorization as a medicine and therefore remains strictly within the research domain.

An important point of orientation: Thymosin Alpha-1 and Thymosin Beta-4 (TB-500) share only the historical name component "thymosin," because both were originally isolated from the same thymic fraction. Structurally and functionally they are entirely different. Thymosin Beta-4 is an actin-binding repair peptide, while Thymosin Alpha-1 is an immune modulator with no meaningful direct repair function. This distinction is critical for any research planning.

Mechanisms of Action

Thymosin Alpha-1 does not act through a single receptor but produces a broad spectrum of immunoregulatory effects. It behaves more like a biological switch that strengthens or rebalances the immune response depending on the starting state. The principal mechanisms characterized in research include:

Maturation and differentiation of T-lymphocytes: Thymosin Alpha-1 promotes the development of immature progenitor cells into functional T-cells. It particularly supports the maturation of CD4-positive helper cells and CD8-positive cytotoxic T-cells, which are responsible for the targeted defense against virus-infected and abnormal cells.
Activation of dendritic cells via Toll-like receptors: Tα1 interacts with Toll-like receptors, primarily TLR2 and TLR9, on dendritic cells and monocytes. This TLR signaling enhances antigen presentation and bridges the innate and adaptive arms of immunity.
Modulation of the cytokine environment: In preclinical models, Thymosin Alpha-1 increases the production of interferon-gamma, interleukin-2, and other Th1-oriented cytokines. This shift toward a Th1 response favors cell-mediated immunity against intracellular pathogens.
Enhancement of natural killer cell activity: Research has observed increased cytotoxic activity of NK cells, which serve as a first line of defense against virus-infected and tumor-like altered cells.
Regulation of immune balance: Thymosin Alpha-1 acts in a context-dependent manner. Where immune function is suppressed it supports the immune response; where inflammation is excessive it can act as a regulator, helping to restore immune homeostasis.
Reduction of oxidative stress and immune-cell apoptosis: Preclinical data suggest that Tα1 may reduce the premature programmed cell death of lymphocytes and mitigate oxidative burden within the immune system.

Dosage Calculation

Thymosin Alpha-1 is dosed in milligrams in research and is typically administered subcutaneously. Dosing is guided by the specific research question; most protocols use a fixed dose without an ascending titration.

Standard Dosing Parameters

Conservative dose: 0.8 mg (800 mcg) per injection
Standard dose: 1.6 mg (1,600 mcg) per injection, corresponding to a common vial content
Higher range: 3.2 mg (3,200 mcg) per injection
Frequency: 2 to 7 times per week, depending on the research protocol
Typical syringe: 0.5 mL or 1 mL insulin syringe (29 to 31 gauge)

Example Calculation: 10 mg Vial with 1 mL BAC Water

Thymosin Alpha-1 is commonly supplied in 10 mg vials. Reconstituting a 10 mg vial with 1 mL of bacteriostatic water yields a concentration of 10 mg/mL (10,000 mcg/mL).

0.8 mg dose: 800 ÷ 10000 = 0.08 mL (8 units on a U100 syringe)
1.6 mg dose: 1600 ÷ 10000 = 0.16 mL (16 units)
3.2 mg dose: 3200 ÷ 10000 = 0.32 mL (32 units)

At a standard dose of 1.6 mg, a 10 mg vial provides six full doses plus a remainder. Because vial sizes and reconstitution volumes vary widely, the precise injection volume should be determined individually for each protocol. The Thymosin Alpha-1 calculator above computes the exact volume for any combination of vial size, BAC water amount, and target dose.

Reconstitution

Thymosin Alpha-1 is supplied as a lyophilized, freeze-dried powder in sealed vials and must be dissolved before use. For multi-dose vials, bacteriostatic water (BAC water) is the appropriate diluent, because its 0.9 percent benzyl alcohol content inhibits microbial growth and extends the usable window of the reconstituted solution. Sterile water for injection is suitable only for vials that will be fully consumed in a single session.

Step-by-Step Reconstitution Protocol

Gather supplies: the Thymosin Alpha-1 vial, a vial of BAC water, alcohol swabs, a sterile draw needle (18 to 21 gauge), and the insulin syringe for injection.
Wipe the rubber septa of both vials with fresh alcohol swabs and allow them to air-dry for about 30 seconds. Do not touch or blow on the septa afterward.
Draw the desired volume of BAC water into the draw syringe, for example 1 mL for a 10 mg vial to obtain a concentration of 10 mg/mL.
Insert the needle into the peptide vial at an angle, directing the tip toward the inner glass wall rather than directly onto the powder cake. Spraying diluent straight onto the powder can shear delicate peptide bonds and damage the molecule.
Push the plunger slowly so the BAC water runs down the inside wall of the vial and gently wets the powder from below.
Carefully roll or gently swirl the vial between your palms until the powder has dissolved completely. The finished solution should be clear and colorless. Never shake or vortex the vial, as mechanical stress can denature the peptide.
Label the vial with the reconstitution date and concentration, for example "Thymosin Alpha-1 10 mg/mL, reconstituted [date]."

If the solution appears cloudy, discolored, or contains visible particulate matter, discard the vial and do not use it.

Storage and Shelf Life

Lyophilized powder (unreconstituted): Store at −20°C for long-term storage; in this state Thymosin Alpha-1 is stable for 24+ months. Short-term storage at 2 to 8°C in a refrigerator is acceptable for several weeks. Protect from light and moisture.
Reconstituted solution: Always store in the refrigerator at 2 to 8°C. Solutions prepared with BAC water are stable for approximately 28 to 30 days. Keep the vial upright and away from light, and discard it after the usable window regardless of remaining volume.
Do not freeze reconstituted peptide. Freeze-thaw cycles cause protein aggregation and a loss of biological activity. Once reconstituted, the vial must remain refrigerated throughout.
Transport: For any travel lasting more than one to two hours, use an insulated cooler with an ice pack. Commercial insulated medication pouches maintain 2 to 8°C for 24 to 48 hours. Avoid exposure to temperatures above 25°C during transport.

Side Effects and Safety Profile

Thymosin Alpha-1 shows a consistently favorable tolerability profile across numerous preclinical and clinical investigations. As a fragment of an endogenous thymic protein, it has not produced organ toxicity, mutagenic effects, or hormonal disruption even at higher doses. Because it is an immune-modulating peptide, however, some aspects warrant particular attention.

Commonly Reported Observations

Mild redness, transient swelling, or brief discomfort at the injection site. These local reactions resolve within a few hours in most users; rotating injection sites minimizes localized irritation.
Occasional mild fatigue or a flu-like feeling during the first days of a protocol, likely related to the activation of the immune response, which usually subsides quickly.
Occasional mild headache or brief chills after injection, which typically resolve on their own.

Less Common or Theoretical Concerns

Autoimmune predisposition: Because Thymosin Alpha-1 strengthens cell-mediated immunity, it could theoretically promote an overactive immune response in individuals with existing autoimmune disease. Particular caution is warranted in such contexts.
Interaction with immunosuppressive medication: When taken alongside immunosuppressants, for example after organ transplantation, the immune-activating action of Tα1 could theoretically counteract that therapy. This interaction is not well characterized.
Allergic reactions: As with any injectable peptide, rare hypersensitivity reactions are possible. Persistent or pronounced local reactions should be treated as a possible sign of sensitization.

Contraindications

Existing autoimmune disease without specialist supervision
Post organ transplantation status or ongoing immunosuppressive therapy
Pregnancy and breastfeeding, as robust safety data are lacking
Known hypersensitivity to any component of the preparation

In the published literature, few serious adverse events have been reported in approved clinical applications. Because Thymosin Alpha-1 is not authorized as a medicine in the EU and is supplied strictly for research purposes, consultation with a qualified healthcare professional before any use is strongly recommended.

Combinations and Stacks

Thymosin Alpha-1 plus BPC-157

Thymosin Alpha-1 covers a mechanism the classic repair peptides do not address: immune regulation. In research contexts it is therefore occasionally considered alongside BPC-157. While BPC-157 drives angiogenesis, collagen synthesis, and gastrointestinal healing, Thymosin Alpha-1 addresses the immunological component of recovery and stress. The two peptides act on fundamentally different axes and have essentially no mechanistic overlap.

Thymosin Alpha-1 and the Thymosin Beta-4 Misconception

Because of the shared name component, Thymosin Alpha-1 and TB-500 (Thymosin Beta-4) are frequently mentioned side by side in the research literature. Functionally, however, they are clearly distinct: TB-500 is an actin-binding repair and migration peptide, while Thymosin Alpha-1 is a pure immune modulator. Anyone considering both within a protocol should treat them as two independent tools serving different questions, not as related substances with similar effects.

Thymosin Alpha-1 plus KPV

For research questions around inflammation modulation, Thymosin Alpha-1 is sometimes considered alongside KPV. KPV is a short anti-inflammatory tripeptide that dampens pro-inflammatory signaling pathways, while Thymosin Alpha-1 regulates immune balance at the level of T-cell maturation. Both address the immune system from complementary angles: KPV more by dampening, Thymosin Alpha-1 more by rebalancing.

Thymosin Alpha-1 is not currently listed in the BergdorfBio range. Available peptides can be found in the BergdorfBio product catalog. All products are offered strictly for research purposes.

Frequently Asked Questions

Is Thymosin Alpha-1 the same as Thymosin Beta-4 or TB-500?

No. Both peptides carry the name component "thymosin" because they were historically isolated from the same thymic fraction, but they are structurally and functionally entirely different. Thymosin Alpha-1 is an immune-modulating peptide of 28 amino acids; Thymosin Beta-4 is an actin-binding repair peptide of 43 amino acids. They are not interchangeable.

How is Thymosin Alpha-1 administered?

In research, Thymosin Alpha-1 is usually injected subcutaneously, that is into the tissue just below the skin, most often in the abdominal area. Subcutaneous injection allows steady absorption. There is no reliable oral form, since the peptide would be broken down in the gastrointestinal tract.

How often is Thymosin Alpha-1 dosed in protocols?

Frequency ranges from twice to seven times per week depending on the research protocol. More intensive protocols use daily or near-daily dosing over a limited period, while others rely on two to three injections per week across longer cycles. An ascending titration is generally not required.

Does Thymosin Alpha-1 affect hormone levels?

No. Thymosin Alpha-1 does not bind to hormone receptors and does not interact with the hypothalamic-pituitary axis, thyroid function, or sex hormones. It acts purely as an immune modulator, so no post-cycle therapy is required.

How long does a typical Thymosin Alpha-1 cycle last?

Research protocols frequently run over four to eight weeks, and longer in some questions. Because Thymosin Alpha-1 modulates immune balance, continuous use over many months without a break is uncommon in research. Specific cycle lengths depend entirely on the study design in question.

Is Thymosin Alpha-1 an approved medicine?

In some countries Thymosin Alpha-1 is approved as a prescription medicine under the brand name Zadaxin, for example as an adjunct in certain viral infections. In the European Union it holds no marketing authorization as a medicine. The material described here is supplied strictly for research purposes and is not intended for human use.

Is Thymosin Alpha-1 relevant to sports drug testing?

Thymosin Alpha-1 is not a growth factor and not an anabolic hormone. It does not fall into the same category as performance-enhancing peptides. Athletes subject to anti-doping regulations should nonetheless always check the current WADA prohibited list, since classifications can change.

Can Thymosin Alpha-1 be mixed with other peptides?

Although some users combine multiple peptides immediately before injection, it is safer to reconstitute each peptide individually and inject them separately. Combined stability in solution is often not characterized, and separate injections eliminate dosing errors and undesirable in-solution interactions.

Medical Disclaimer: The information on this page is provided for educational and research purposes only. Thymosin Alpha-1 is not an approved medicine in the European Union and is supplied strictly for research use. Nothing on this page constitutes medical advice, a diagnosis, or a recommendation to use any specific compound. Always consult a qualified healthcare professional before considering any peptide protocol. BergdorfBio assumes no liability for the use or misuse of the information presented here.

Žingsnis po žingsnio

Kaip ištirpinti peptidą

Nuo miltelių iki paruošto švirkšto per penkis žingsnius. Kiekius automatiškai apskaičiuoja aukščiau esanti skaičiuoklė.

011
Paruoškite BAC vandenį
Leiskite flakonui ir vandeniui sušilti iki kambario temperatūros. Nuvalykite abu guminius kamštelius alkoholiu.
022
Įtraukite vandenį
Didesniu švirkštu įtraukite skaičiuoklės rekomenduojamą BAC vandens kiekį.
033
Pilkite lėtai
Leiskite vandeniui tekėti peptido flakono sienele, nepurkškite jo tiesiai ant miltelių.
044
Leiskite ištirpti
Atsargiai pasukite flakoną, nekratykite. Milteliai ištirps ir tirpalas taps skaidrus per 1-2 minutes.
055
Įtraukite dozę
Insulino švirkštu įtraukite tiksliai iki apskaičiuotos žymės. Paruošta.

Nuoroda

Dozės ir flakonų dydžiai pagal peptidą

Įprastos pradinės reikšmės orientacijai. Kiekviena eilutė atidaro to peptido skaičiuoklę.

Peptidas	Kategorija	Įprasta dozė	Flakonų dydžiai	BAC (pradžiai)	Prieinamumas	Skaičiuoti
VIP	Nevropeptidų tyrimai	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Retatrutide	GLP-1/GIP/GCG	0,5-12 mg	2 / 5 / 10 / 15 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Cagrilintide	Amilino analogas	-	5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Semaglutide	GLP-1	0,25-2,4 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Tirzepatide	GLP-1/GIP	2,5-15 mg	10 / 15 / 20 / 30 / 60 / 90 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHK-Cu	Vario peptidas	1-4 mg	10 / 20 / 50 mg	5 ml	Tik skaičiuoklė	Skaičiuoti
AHK-Cu	Vario peptidas	-	100 mg	5 ml	Tik skaičiuoklė	Skaičiuoti
BPC-157	Audinių atkūrimas	0,2-0,5 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
TB-500	Thymosin Beta-4	2-5 mg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
CJC-1295 (be DAC)	GHRH analogas	100-200 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Ipamorelin	GHRP	200-300 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
AOD-9604	Riebalų apykaita	250-500 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
PT-141	Bremelanotide	-	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
MOTS-c	Mitochondrinis	5-10 mg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Selank	Anksiolitinis	150-500 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
SS-31	Elamipretide	0,1-1 mg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Glow Stack	Stack	0,5-2 mg	70 mg	3 ml	Tik skaičiuoklė	Skaičiuoti
Klow Stack	Stack	0,5-2 mg	55 mg	3 ml	Tik skaičiuoklė	Skaičiuoti
Melanotan II	Melanokortinas	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Melanotan I	Melanokortinas	-	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Sermorelin	GHRH analogas	50-300 mcg	5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Tesamorelin	GHRH analogas	1-2 mg	10 / 20 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Thymosin Alpha-1	Timuso peptidas	0,8-3,2 mg	1.6 / 5 / 10 mg	1 ml	Tik skaičiuoklė	Skaičiuoti
Epithalon	Ilgaamžiškumas	2-10 mg	10 / 20 / 50 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
KPV	Imuninė sistema / barjeras	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
HGH Fragment 176-191	Metabolinis fragmentas	100-500 mcg	2 / 5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Semax	Kognityvinis	100-1000 mcg	10 / 30 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
N-Acetyl Semax	Kognityvinis	100-1000 mcg	5 / 10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Hexarelin	GHRP	50-200 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHRP-6	GHRP	50-300 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
GHRP-2	GHRP	50-250 mcg	2 / 5 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
DSIP	Miegas	50-500 mcg	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
5-Amino-1MQ	Metabolinis	2,5-10 mg	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Pinealon	Tiriamasis peptidas	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Survodutide	GLP-1/glukagonas	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
Kisspeptin-10	KISS1R / GPR54	-	10 mg	2 ml	Tik skaičiuoklė	Skaičiuoti
HGH 191AA	Augimo hormonas	1-5 mg	10 mg	1 ml	Tik skaičiuoklė	Skaičiuoti
NAD+	Ilgaamžiškumas / kofaktorius	100-500 mg	1000 mg	10 ml	Tik skaičiuoklė	Skaičiuoti

Reikšmės skirtos orientacijai tyrimų kontekste ir nepakeičia profesionalios konsultacijos.

Kodėl tikslus peptido dozavimas svarbus

Koncentracijos ir injekcijos tūrio apskaičiavimas atrodo paprastas, tačiau tai dažniausia klaidų priežastis. Net 10 % paklaida ištirpinant reiškia, kad veikliosios medžiagos gausite per mažai arba netyčia suleisite per daug.

Liofilizuoti peptidai tiekiami miligramais ir ištirpinami bakteriostatiniame vandenyje (BAC vanduo). Peptido ir vandens santykis lemia koncentraciją, o iš jos išplaukia, kiek vienetų įtrauksite į insulino švirkštą. Insulino švirkštai graduoti vienetais, o ne miligramais. Skaičiuoklė atlieka šį perskaičiavimą ir patikrina patikimumą dėl pavojingiausios klaidos: supainioti mg ir mcg.

DUK

Dažnai užduodami klausimai

Kuo skiriasi mcg ir mg?

Miligramas (mg) yra vienetas, kuriuo parduodami liofilizuoti peptidai, pavyzdžiui, „5 mg BPC-157“. Mikrogramas (mcg) matuoja vienkartinę dozę, pavyzdžiui, „250 mcg vienai injekcijai“. 1 mg = 1 000 mcg. Skaičiuoklė perskaičiuoja automatiškai ir įspėja, jei įvestis atrodo kaip supainioti vienetai.

Ką reiškia „U-100“ ant insulino švirkšto?

U-100 reiškia, kad švirkštas sugraduotas 100 vienetų mililitre. 100 IU = 1 ml, todėl 10 IU = 0,10 ml, nepriklausomai nuo to, kas yra švirkšte. IU skaičiavimas pagrįstas būtent šiuo santykiu.

Kodėl skaičiuoklė kartais rodo labai mažus tūrius?

Kai peptido daug, o vandens mažai, tirpalas tampa labai koncentruotas, todėl vienos dozės tūris būna mažas ir sunkiai nuskaitomas. Naudokitės rekonstitucijos pagalbininku: jis suranda vandens kiekį, kuris duoda aiškią, lengvai nuskaitomą žymę.

Kiek laiko išsilaiko ištirpintas peptidas?

Šaldytuve 2-8 °C temperatūroje paprastai 21-30 dienų. Pažymėkite ant flakono rekonstitucijos datą. Drumstas tirpalas ar dalelės netinka.

Kaip skaičiuoklė veikia su mišiniais, pavyzdžiui, Glow Stack?

Mišiniuose viename flakone yra kelios veikliosios medžiagos. Tiesiog pasirinkite mišinį kaip peptidą: skaičiuoklė papildomai parodys, kiek kiekvieno komponento yra Jūsų injekcijoje. Jei norite derinti kelis atskirus flakonus, naudokitės stackų kūrėju.

Ar skaičiuoklę reikia pildyti kaskart iš naujo?

Ne. Paskutiniai nustatymai saugomi šioje naršyklėje ir atkuriami kitą kartą. Skaičiavimus galite atkurti ir iš istorijos, išsaugoti kaip protokolą arba bendrinti nuoroda.

Susiję peptidai

TB-500Thymosin Beta-4 BPC-157Audinių atkūrimas KPVImuninė sistema / barjeras

Visos skaičiuoklės

Pasirinkite peptidą

Pasirinkite peptidą, kad atidarytumėte jo skaičiuoklės puslapį su iš anksto užpildytomis reikšmėmis.

Thymosin Alpha-1 skaičiuoklė

Pagrindiniai duomenys

What Is Thymosin Alpha-1?

Mechanisms of Action

Dosage Calculation

Standard Dosing Parameters

Example Calculation: 10 mg Vial with 1 mL BAC Water

Reconstitution

Step-by-Step Reconstitution Protocol

Storage and Shelf Life

Side Effects and Safety Profile

Commonly Reported Observations

Less Common or Theoretical Concerns

Contraindications

Combinations and Stacks

Thymosin Alpha-1 plus BPC-157

Thymosin Alpha-1 and the Thymosin Beta-4 Misconception

Thymosin Alpha-1 plus KPV

Frequently Asked Questions

Is Thymosin Alpha-1 the same as Thymosin Beta-4 or TB-500?

How is Thymosin Alpha-1 administered?

How often is Thymosin Alpha-1 dosed in protocols?

Does Thymosin Alpha-1 affect hormone levels?

How long does a typical Thymosin Alpha-1 cycle last?

Is Thymosin Alpha-1 an approved medicine?

Is Thymosin Alpha-1 relevant to sports drug testing?

Can Thymosin Alpha-1 be mixed with other peptides?

Kaip ištirpinti peptidą

Paruoškite BAC vandenį

Įtraukite vandenį

Pilkite lėtai

Leiskite ištirpti

Įtraukite dozę

Dozės ir flakonų dydžiai pagal peptidą

Kodėl tikslus peptido dozavimas svarbus

Dažnai užduodami klausimai

Susiję peptidai

Pasirinkite peptidą

VIP

Retatrutide

Cagrilintide

Semaglutide

Tirzepatide

GHK-Cu

AHK-Cu

BPC-157

TB-500

CJC-1295 (be DAC)

Ipamorelin

AOD-9604

PT-141

MOTS-c

Selank

SS-31

Glow Stack

Klow Stack

Melanotan II

Melanotan I

Sermorelin

Tesamorelin

Epithalon

KPV

HGH Fragment 176-191

Semax

N-Acetyl Semax

Hexarelin

GHRP-6

GHRP-2

DSIP

5-Amino-1MQ

Pinealon

Survodutide

Kisspeptin-10

HGH 191AA

NAD+

Thymosin Alpha-1 skaičiuoklė

Pagrindiniai duomenys

What Is Thymosin Alpha-1?

Mechanisms of Action

Dosage Calculation